A European law that prevents the patenting of discoveries that contravene morality is causing confusion when it comes to human embryonic stem cells. The ensuing debate is markedly different from the one in the United States, where the scope of stem cell patents and their licensing are under challenge.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.cell.2008.02.012 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!